FDA to more aggressively tackle disruptive drug shortages

July 12, 2018 by Linda A. Johnson
FDA to more aggressively tackle disruptive drug shortages
This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The FDA said Thursday, July 12, 2018, it plans to more aggressively fight the persistent medication shortages that have led to rationing, disrupted hospital operations and even compromised patient care. It's a new approach for the drug regulator, which has typically waited until shortages began or were imminent to take action. (AP Photo/Andrew Harnik, File)

The U.S. Food and Drug Administration wants to more aggressively fight medication shortages that recently have led to rationing of some drugs and disrupted hospital operations.

The FDA said Thursday that it's forming a to find ways to improve the supply of crucial drugs. It's a new approach for the drug regulator, which has no control over companies. It generally can't act until drugmakers say shortages are imminent.

Many shortages involve low-profit generic pills and injections that are hospital workhorses, like antibiotics and painkillers. Many are made by only a few companies so when production problems occur, other drugmakers can't make up for the shortfall.

Explore further: FDA names drugmakers accused of blocking cheaper generics

Related Stories

FDA names drugmakers accused of blocking cheaper generics

May 17, 2018
U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.

FDA enlists companies to head off drug shortages

October 31, 2013
The Food and Drug Administration is announcing a new proposal designed to head off more shortages of crucial medications that have disrupted care at hospitals and health clinics nationwide.

Hospital groups creating company to make cheap generic drugs

January 18, 2018
Several major not-for-profit hospital groups are trying their own solution to drug shortages and high medicine prices: creating a company to make cheaper generic drugs.

Drug shortages pose a public health crisis in the US

June 18, 2018
On June 12, the American Medical Association announced that drug shortages pose an urgent public health crisis. This crisis should be of concern to all Americans.

FDA: Drug shortages possible due to Puerto Rico power outage

October 7, 2017
The U.S. Food and Drug Administration says drug shortages are possible because of expected long-term power outages in Puerto Rico.

The creeping problem of drug shortages

June 28, 2018
Dozens of drugs are suddenly unavailable every year. In Canada, we read about shortages of Epipens, opioids and antibiotics and before that, it was saline. In India, it is anti-HIV drugs for children. The problem is global, ...

Recommended for you

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

Rise in meth and opioid use during pregnancy

November 29, 2018
Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in rural counties.

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.